Is Adagio Medical Holdings, Inc. (ADGM) a Buy, Sell, or Hold?
NASDAQ : ADGM
Adagio Medical Holdings, Inc.
$0.53 USD
$0 (0.0%)
- Volume
- 35.36K
- Average Volume
- 101.27K
- Market Capitalization
- $8.07M
- P/E Ratio
- -0.38
- Dividend Yield
- 0.00%
- Price Target
- $3.00
- Year High
- $2.58
- Year Low
- $0.51
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.85
Company Overview
NASDAQ
Todd Usen
Medical - Devices
Healthcare
ADGM
41
US
USD
Liquidity Metrics
4.21
1.85
1.66
1.51
0.00
Sales & Valuation
-$
0.00
2.06
-0.52
-0.70
Profitability
-$1.51
-$25.08M
0.00%
0.00%
-382.50%
-61.99%
P/E Metrics
-0.38
-0.01
-0.01
Analyst Price Target & Rating
$3.00
$3.00
$3.00
1/5
0 Analysts
-82.33%
Poll Results
About Adagio Medical Holdings, Inc. (NASDAQ:ADGM) Stock
Adagio Medical Holdings, Inc. is an emerging medical device firm focused on pioneering and commercializing innovative ablation technologies. Its core mission is to provide therapeutic solutions for various cardiac rhythm disorders, including but not limited to atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's current product portfolio showcases advanced offerings such as the iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and its complementary accessories, the vCLAS ventricular ULTC catheter, and the Cryopulse atrial pulsed-field cryoablation catheter, also available with associated accessories. This entity, which commenced operations in 2011, has its principal office situated in Laguna Hills, California. ...
Robo.ai Announces Core Executive Appointments, Forming a Local UAE Leadership Team at Neurovia AI
2026-07-14 02:00:00
Robo.ai Announces Core Executive Appointments, Forming a Local UAE Leadership Team at Neurovia AI PR Newswire AB
2026-05-21 08:00:00
LAGUNA HILLS, Calif.--(BUSINESS WIRE)---- $ADGM #ARRHYTHMIA--Adagio Medical Holdings, Inc (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced the submission of its Premarket Approval (“PMA”) application to the U.S. Food and Drug Administration (“FDA”) for the vCLAS Ventricular Ablation System for the treatment of drug-refractory, recurrent, sustained monomorphic ventricular tachycardia (“VT”) in patients with isch.
Adagio Medical Reports First Quarter 2026 Results and Meaningful Clinical Progress
2026-05-12 08:05:00
LAGUNA HILLS, Calif.--(BUSINESS WIRE)---- $ADGM #ARRHYTHMIA--Adagio Medical Holdings, Inc (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced financial results for the first quarter ended March 31, 2026. Recent Business Highlights: Pivotal results from the FULCRUM-VT trial presented in late-breaking session at Heart Rhythm Society 2026 – the first large-scale, rigorously executed pivotal trial in patients with bot.
Adagio Medical to Participate in the BofA Securities 2026 Health Care Conference
2026-04-29 08:00:00
LAGUNA HILLS, Calif.--(BUSINESS WIRE)---- $ADGM #ARRHYTHMIA--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that management will be presenting at the BofA Securities 2026 Healthcare Conference on Wednesday, May 13, 2026 at 4:35pm PDT in Las Vegas. Presentation Information A live webcast and replay of the session will be accessible at https://bofa.veracast.com/webcasts/bofa/health.
Adagio Medical Announces Positive Pivotal Results for vCLAS® Ventricular Ablation System
2026-04-26 09:32:00
LAGUNA HILLS, Calif.--(BUSINESS WIRE)---- $ADGM #Arrhythmia--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today reported six month results from its FULCRUM-VT Investigational Device Exemption (“IDE”) clinical trial, which will be used to support the Company's application for Food and Drug Administration (“FDA”) Premarket Approval of the vCLAS Ventricular Ablation System. The results were prese.
Adagio Medical Holdings, Inc. (NASDAQ:ADGM) Sees Large Growth in Short Interest
2026-04-26 03:13:08
Adagio Medical Holdings, Inc. (NASDAQ: ADGM - Get Free Report) was the recipient of a large increase in short interest in April. As of April 15th, there was short interest totaling 50,386 shares, an increase of 106.5% from the March 31st total of 24,396 shares. Based on an average trading volume of 299,319 shares, the short-interest
Frequently Asked Questions
-
What is the current Adagio Medical Holdings, Inc. (ADGM) stock price?
-
Adagio Medical Holdings, Inc.(NASDAQ:ADGM) stock price is $0.53 in the last trading session. During the trading session, ADGM stock reached the peak price of $2.582 while $0.512 was the lowest point it dropped to. The percentage change in ADGM stock occurred in the recent session was 0.0% while the dollar amount for the price change in ADGM stock was $0.
-
ADGM's industry and sector of operation?
-
The NASDAQ listed ADGM is part of Medical - Devices industry that operates in the broader Healthcare sector.
-
Who are the executives of ADGM?
-
Antwan Gipson | Senior Vice President of Manufacturing & Operations
Maryline Cullen | VP & Corporate Controller
Deborah Kaster | Chief Financial Officer & Chief Business Officer
Alex Babkin | Chief Technical Officer
Ilya Grigorov | Vice President of Global Marketing & Product Management -
How many employees does ADGM have?
-
Number of ADGM employees currently stands at 41. ADGM operates from 26051 Merit Circle, Laguna Hills, CA 92653, US.
-
Link for ADGM official website?
-
Official Website of ADGM is: https://adagiomedical.com
-
How do I contact ADGM?
-
ADGM could be contacted at phone #949-348-1188 and can also be accessed through its website. ADGM operates from 26051 Merit Circle, Laguna Hills, CA 92653, US.
-
How many shares of ADGM are traded daily?
-
The average number of ADGM shares traded daily for last 3 months was 101.27K.
-
What is the market cap of ADGM currently?
-
The market value of ADGM currently stands at $8.07M with its latest stock price at $0.53